Skip to main content
. 2021 Oct 4;11:728583. doi: 10.3389/fonc.2021.728583

Figure 4.

Figure 4

Knockdown of SMAD2 or SMAD3 can inhibit the expression of NGF and BDNF. (A, B) qPCR and Western blotting analysis of the expression of SMAD2, SMAD3, NGF, BDNF in PANC-1 cell line after treated with SMAD2-specific siRNAs; (C, D) qPCR and Western blotting analysis of the expression of SMAD3, SMAD2, NGF, BDNF in PANC-1 cell line after treated with SMAD3-specific siRNAs; (E) qPCR analysis of the expression of NGF, BDNF in PANC-1 cell line after treated with TGFβ-1 and SMAD2-specific siRNAs; (F) Western blotting analysis of the expression of SMAD2, NGF, BDNF in PANC-1 cell line after treated with TGFβ-1 and SMAD2-specific siRNAs; (G) qPCR analysis of the expression of NGF, BDNF in PANC-1 cell line after treated with TGFβ-1 and SMAD3-specific siRNAs; (H) Western blotting analysis of the expression of SMAD3, NGF, BDNF in PANC-1 cell line after treated with TGFβ-1 and SMAD3-specific siRNAs. *p < 0.05, **p < 0.01; # p < 0.05, ## p < 0.01.